A Trial in Painful Diabetic Peripheral Neuropathy With GRT3983Y
A Trial in Painful Diabetic Peripheral Neuropathy With GRT3983Y
This trial is assessing the analgesic efficacy and safety of a new central analgesic in
 subjects with pain due to diabetic peripheral neuropathy (DPN).
Inclusion Criteria:

 -  Symmetrical painful diabetic peripheral neuropathy

 Exclusion Criteria:

 -  History of hypersensitivity, allergy or contraindication to opioids and acetaminophen

 -  Confounding painful conditions

 -  Significant vascular disease

 -  History or risk of seizure

 -  Chronic disease that might effect drug absorption, distribution, metabolism, or
 excretion

 -  Female subjects who are being pregnant or breastfeeding

 -  Evidence or history of alcohol, medication, or drug abuse